Isolation of rare circulating tumor cells in cancer patients: technical aspects and clinical implications

References

• Gerges N, Jabado N. Biomarkers in cancer micrometastasis: where are we at? Bioanalysis2, 881–899 (2010).
   PubMedGoogle Scholar
• Criscitiello C, Sotirou C, Ignatiadis M. Circulating cancer cells and emerging blood biomarkers in breast cancer. Curr. Opin. Oncol.22, 552–558 (2010).
   PubMedGoogle Scholar
• Allard WJ, Matera J, Miller MC et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin. Cancer Res.10, 6897–6904 (2004).
   PubMed Web of Science ®Google Scholar
• Elshimali YI, Grody WW. The clinical significance of circulating tumor cells in the peripheral blood. Diagn. Mol. Pathol.15, 187–194 (2006).
   PubMedGoogle Scholar
• Paterlini-Brechot P, Benali NL. Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Lett.253, 180–204 (2007).
   PubMed Web of Science ®Google Scholar
• Andreopoulov E, Cristofanilli M. Circulating tumor cells as prognostic markers in metastatic breast cancer. Exp. Rev. Anticancer Therapy10, 171–177 (2010).
   PubMedGoogle Scholar
• Mavroudis D. Circulating cancer cells. Ann. Oncol.21(Suppl. 7), vii95–vii100 (2011).
   Google Scholar
• Cristofanilli M, Braun S. Circulating tumor cells revisited. JAMA303, 1092–1093 (2010).
   PubMedGoogle Scholar
• Jacob K, Sollier C, Jabado N. Circulating tumor cells: detection, molecular profiling and future prospects. Expert Rev. Proteomics4, 741–756 (2007).
   PubMed Web of Science ®Google Scholar
• Mata M, Raponi M. Circulating tumor cells: utility for predicting response to anti-EGFR therapies? Expert Rev. Mol. Diagn.9, 115–119 (2009).
   PubMed Web of Science ®Google Scholar
• Stakeborg T, Liu C, Henry O et al. Automated genotyping of circulating tumor cells. Expert Rev. Mol. Diagn.10, 723–729 (2010).
   PubMedGoogle Scholar
• Ignatiadis M, Rothè F, Chaboteaux C et al. HER-positive circulating tumor cells in breast cancer. PLoS One6, 1–6 (2011).
   Google Scholar
• Den Tonder J. Circulating tumor cells: the Grand Challenge. Lab. Chip11, 375–377 (2011).
   PubMedGoogle Scholar
• Sieuwerts AM, Kraan J, Bolt J et al. Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumour cells. J. Natl Cancer Inst.101, 61–66 (2009).
   PubMed Web of Science ®Google Scholar
• Dotan E, Cohen SJ, Alpaugh KR, Meropol NJ. Circulating tumor cells: evolving evidence and future challenges. Oncologist14, 1070–1082 (2009).
   PubMed Web of Science ®Google Scholar
• Barok M, Szollosi J. Steps in metastasis research: analyzing, collecting and culturing circulating tumor cells. Cytometry Part A79A, 93–94 (2011).
   Google Scholar
• Yu M, Stott S, Toner M, Maheswaran S, Haber DA. Circulating tumor cells: approaches to isolation and characterization. J. Cell. Biol.192, 373–382 (2011).
   PubMed Web of Science ®Google Scholar
• Nelson NJ. Circulating tumor cells: will they be clinically useful? J. Natl Cancer Inst.102, 146–148 (2010).
   PubMed Web of Science ®Google Scholar
• Riethdorf S, Pantel K. Advancing personalized cancer therapy by detection and characterization of circulating carcinoma cells. Ann. NY Acad. Sci.1210, 66–77 (2010).
   PubMed Web of Science ®Google Scholar
• Lin H, Balic M, Zheng S, Datar R, Cote RJ. Disseminated and circulating tumor cells: role in effective cancer management. Crit. Rev. Oncol. Hematol.77, 1–11 (2011).
   PubMedGoogle Scholar
• Alunni-Fabbroni M, Sandri MT. Circulating tumour cells in clinical practice: methods of detection and possible characterization. Methods50, 289–297 (2010).
   PubMed Web of Science ®Google Scholar
• Gerges N, Rak J, Jabado N. New technologies for the detection of circulating tumor cells. Br. Med. Bull.94, 49–64 (2010).
   PubMed Web of Science ®Google Scholar
• Rosenberg R, Gertler R, Friederichs J et al. Comparison of two density gradient centrifugation systems for the enrichment of disseminated tumor cells in blood. Cytometry49, 150–158 (2002).
   PubMedGoogle Scholar
• Gertler R, Rosenberg R, Fuehrer K et al. Detection of circulating tumor cells in blood using an optimized density gradient centrifugation. Recent Results Cancer Res.162, 149–155 (2003).
   PubMedGoogle Scholar
• Zheng S, Lin H, Liu JQ et al. Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells. J. Chromatogr. A.1162, 154–161 (2007).
   PubMed Web of Science ®Google Scholar
• Wong NS, Kahn HJ, Zhang L et al. Prognostic significance of circulating tumour cells enumerated after filtration enrichment in early and metastatic breast cancer patients. Breast Cancer Res. Treat.99, 63–69 (2006).
   PubMedGoogle Scholar
• De Giorgi V, Pinzani P, Salvianti F et al. Application of a filtration- and isolation-by-size tehcnique for the detection of circulating tumor cells in cutaneous melanoma. J. Invest. Dermatol.130, 2440–2447 (2010).
   PubMed Web of Science ®Google Scholar
• Xu T, Lu B, Tai YC, Goldkorn A. A cancer detection platform which measures telomerase activity from live circulating tumor cells captured on a microfilter. Cancer Res.70, 6420–6426 (2010).
   PubMed Web of Science ®Google Scholar
• Zheng S, Lin HK, Lu et al. 3D microfilter device for viable circulating tumor cell (CTC) enrichment from blood. Biomed. Microdevices13, 203–213 (2011).
   PubMed Web of Science ®Google Scholar
• Martin VM, Siewert C, Scharl A et al. Immunomagnetic enrichment of disseminated epithelial tumor cells from peripheral blood by MACS. Exp. Hematol.26, 252–264 (1998).
   PubMed Web of Science ®Google Scholar
• Königsberg R, Gneist M, Jahn-Kuch D et al. Circulating tumor cells in metastatic colorectals cancer: efficacy and feasibility of different enrichment methods. Cancer Lett.293, 117–123 (2010).
   PubMed Web of Science ®Google Scholar
• Talasaz AH, Powell AA, Huber DE et al. Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device. PNAS106, 3970–3975 (2009).
   PubMed Web of Science ®Google Scholar
• Cristofanilli M, Budd GT, Ellis MJ et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N. Engl. J. Med.351, 781– 791 (2004).
   PubMed Web of Science ®Google Scholar
• Miller MC, Doyle GV, Terstappen LW. Significance of circulating tumor cells detected by the CellSearch™ system in patients with metastatic breast colorectal and prostate cancer. J. Oncol.2010, 617421 (2010).
   PubMedGoogle Scholar
• Kraan J, Sleijfer S, Strijbos MH et al. External quality assurance of circulating tumor cell enumeration using the CEllSearchTM system: a feasibility study. Cytometry B. Clin. Cytom.80(2), 112–118 (2010).
   PubMedGoogle Scholar
• Mostert B, Kraan J, Bolt-de-Vries J et al. Detection of circulating tumour cells in breast cancer may improve through enrichment with anti-CD146. Breast Cancer Res. Treat.127(1), 33–41 (2010).
   PubMedGoogle Scholar
• Obermayr E, Sanchez-Cabo F, Tea MK et al. Assessment of a six-gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients. BMC Cancer10, 666 (2010).
   PubMedGoogle Scholar
• Simpson SJ, Vachula M, Kennedy MJ et al. Detection of tumor cells in the bone marrow, peripheral blood and apheresis products of breast cancer patients using flow cytometry. Exp. Hematol.23, 1062–1068 (1995).
   PubMed Web of Science ®Google Scholar
• Basiji DA, Ortyn WE, Liang L, Venkatachalam V, Morrissey P. Cellular Image analysis and imaging by flow cytometry. Clin. Lab. Med.27, 653–669 (2007).
   PubMed Web of Science ®Google Scholar
• Will B, Steidl U. Multiparameter fluorescence-activated cell sorting and analysis of stem and progenitor cells in myeloid malignancies. Best Pract. Res. Clin. Hematol.23, 391–401 (2010).
   PubMed Web of Science ®Google Scholar
• Cruz I, Ciudad J, Cruz J et al. Evaluation of multiparameter flow cytometry for the detection of breast cancer tumor cells in blood samples. Am. J. Clin. Pathol.123, 66–74 (2005).
   PubMed Web of Science ®Google Scholar
• Allan AL, Vantyghem SA, Tuck AB, Chambers AP, Chin-Yee IH, Kenney M. Detection and quantification of circulating tumor cells in mouse models of human breast cancer using immunomagnetic enrichment and multiparameter flow cytometry. Cytometry A65, 4–14 (2005).
   PubMed Web of Science ®Google Scholar
• Wang L, Wang Y, Liu Y, Chang M, Wu X, Wie H. Flow cytometric analysis of CK19 expression in the peripheral blood of breast carcinoma patients. Relevance for circulating tumor cell detection. J. Exp. Clin. Cancer Res.28, 28–57 (2009).
   PubMedGoogle Scholar
• Hu Y, Fan L, Zheng J et al. Detection of circulating tumor cells in breast cancer patients utilizing multiparameter flow cytometry and assessment of the prognosis of patients in different CTC levels. Cytometry A77, 213–219 (2010).
   PubMedGoogle Scholar
• Wu LY, Liu T, Grimm AL, Davis WC, Berkman CE. Flow cytometric detection of prostate tumor cells using chemoaffinity labels. Prostate71, 52–61 (2011).
   PubMedGoogle Scholar
• Takao M, Takeda K. Enumeration, characterization and collection of intact circulating tumor cells by cross contamination-free flow cytometry. Cytometry A79, 107–117 (2011).
   PubMed Web of Science ®Google Scholar
• Kraeft SK, Ladanyi A, Galiger K et al. Reliable and sensitive identification of occult tumor cells using the improved rare event imaging system. Clin. Cancer Res.10, 3020–3028 (2004).
   PubMed Web of Science ®Google Scholar
• Pachmann K, Clement JH, Schneider CP et al. Standardized quantification of circulating peripheral tumor cells from lung and breast cancer. Clin. Chem. Lab. Med.43, 617–627 (2005).
   PubMed Web of Science ®Google Scholar
• Scholtens TM, Schreuder F, Ligthart ST et al. CellTracks TDI: an image cytometer for cell characterization. Cytometry A DOI: 10.1002/cyto.a.21024 (2011) (Epub ahead of print).
   Google Scholar
• Smith B, Selby P, Southgate J, Pittman K, Bradley C, Blair GE. Detection of melanoma cells in peripheral blood by means of reverse-transcriptase and polymerase chain reaction. Lancet338, 1227–1229 (1991).
   PubMed Web of Science ®Google Scholar
• Sergeant G, Penninckx F, Topal B. Quantitative RT-PCR detection of colorectal tumor cells in peripheral blood: a systematic review. J. Surg. Res.150, 144–152 (2008).
   PubMedGoogle Scholar
• Ignatiadis M, Xenidis N, Perraki M et al. Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer. J. Clin. Oncol.25, 5194–5202 (2007).
   PubMed Web of Science ®Google Scholar
• Xenidis N, Ignatiadis M, Apostolaki S et al. Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer. J. Clin. Oncol.27, 2177–2184 (2009).
   PubMed Web of Science ®Google Scholar
• Ignatiadis M, Kallergi G, Ntoulia M et al. Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer. Clin. Cancer Res.14, 2593–2600 (2008).
   PubMed Web of Science ®Google Scholar
• Lambrechts AC, Bosma AJ, Klaver SG et al. Comparison of immunocytochemistry, reverse trascriptase polymerase chain reaction, and nucleic acid sequence-based amplification for the detection of circulating breast cancer cells. Breast Cancer Res. Treat.56, 219–231 (1999).
   PubMedGoogle Scholar
• Panteleakou Z, Lembessis P, Sourla A et al. Detection of circulating tumor cells in prostate cancer patients: methodological pitfalls and clinical relevance. Mol. Med.15, 101–114 (2009).
   PubMedGoogle Scholar
• Ross JS, Slodkowska EA. Circulating and disseminated tumor cells in the management of breast cancer. Am. J. Clin. Pathol.132, 237–245 (2009).
   PubMed Web of Science ®Google Scholar
• Alix-Panabieres C, Riethdorf S, Pantel K. Circulating tumor cells and bone marrow micrometastases. Clin. Cancer Res.14, 5013–5021 (2008).
   PubMed Web of Science ®Google Scholar
• Pantel K, Alix-Panabieres C. The clinical significance of circulating tumor cells. Nat. Clin. Pract. Oncol.4, 62–63 (2007).
   PubMedGoogle Scholar
• Hauch S, Zimmermann S, Lankiewicz S, Zieglschmid V, Bocher O, Winfried HA. The clinical significance of circulating tumor cells in breast cancer and colorectal cancer patients. Anticancer Res.27, 1337–1341 (2007).
   PubMedGoogle Scholar
• Kojima T, Hashimoto Y, Watanabe Y et al. A simple biological imaging system for detecting viable human circulating tumor cells. J. Clin. Invest.119, 3172–3181 (2009).
   PubMed Web of Science ®Google Scholar
• Nagrath S, Sequist LV, Maheswaran S et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature450, 1235–1239 (2007).
   PubMed Web of Science ®Google Scholar
• Maheswaran S, Sequist LV, Nagrath S et al. Detection of mutations in EGFR in circulating lung-cancer cells. N. Engl. J. Med.359, 366–377 (2008).
   PubMed Web of Science ®Google Scholar
• Sequist LV, Nagrath S, Toner M, Haber DA, Lynch TJ. The CTC-chip: an exciting new tool to detect circulating tumor cells in lung cancer patients. J. Thorac. Oncol.4, 281–283 (2009).
   PubMed Web of Science ®Google Scholar
• Stott SL, Lee JR, Nagrath S et al. Isolation and characterization of circulating tumour cells from patients with localized and metastatic prostate cancer. Sci. Transl. Med.2(25), 25ra23 (2010).
   PubMed Web of Science ®Google Scholar
• Chatzileontiadou S, Defanti S, Manzoni M et al. Circulating tumour cells in cancer patients: methodological contributions to their detection and immunomagnetic separation. Cytometry77A, 194–195 (2010).
   Google Scholar
• Stott SL, Hsu CH, Tsukrov DI et al. Isolation of circulating tumour cells using a microvortex-generating herringbone-chip. PNAS107, 18392–18397 (2010).
   PubMed Web of Science ®Google Scholar
• Jin D, Piper JA, Leif RC et al. Time-gated flow cytometry: an ultra high selectivity method to recover ultra-rare-event µ-targets in high-background biosamples. J. Biomed. Opt.14, 24–28 (2009).
   Google Scholar
• Liu G, Mao X, Phillips JA, Xu H, Tan W, Zeng L. Aptamer-nanoparticle strip biosensor for sensitive detection of cancer cells. Anal. Chem.81, 10013–10018 (2009).
   PubMed Web of Science ®Google Scholar
• Deng T, Li J, Zhang LL et al. A sensitive fluorescence anisotropy method for the direct detection of cancer cells in whole blood based on aptamer-conjugated near-infrared fluorescent nanoparticles. Biosens. Bioelectron.25, 1587–1591 (2010).
   PubMedGoogle Scholar
• Eifler RL, Lid J, Falkenhagen D, Weber W, Fischer MB, Zeillinger R. Enrichment of circulating tumor cells from a large blood volume using leukapheresis and elutriation: proof of concept. Cytometry B Clin. Cytom.80(2), 100–111 (2010).
   PubMedGoogle Scholar
• Zimmerlin L, Donnenberg VS, Donnenberg AD. Rare event detection and analysis in flow cytometry: bone marrow mesenchymal stem cells, breast cancer stem/progenitor cells in malignant effusions, and pericytes in disaggregate adipose tissue. Methods Mol. Biol.699, 251–273 (2011).
   PubMedGoogle Scholar
• Wang X, Qiang X, Beitler JJ et al. Detection of circulating tumor cells in human peripheral blood using surface-enhanced raman scattering nanoparticles. Cancer Res.71(5), 1526–1532 (2011).
   PubMed Web of Science ®Google Scholar
• Hsieh YH, Liu SJ, Chen HW, Lin YK, Liang KS, Lai LJ. Highly sensitive rare cell detection based on quantum dot probe fluorescence analysis. Anal. Bioanal. Chem.396, 1135–1141 (2010).
   PubMedGoogle Scholar
• Bao N, Le TT, Cheng JX, Lu C. Microfluidic electroporation of tumor and blood cells: observation of nucleus expansion and implications on selective analysis and purging of circulating tumor cells. Integr. Biol.2, 113–120 (2010).
   Google Scholar
• Hosokawa M, Hayata T, Fukuda Y et al. Size-selective microcavity array for rapid and efficient detection of circulating tumor cells. Anal. Chem.82, 6629–6635 (2010).
   PubMed Web of Science ®Google Scholar
• Breton F, Bennettau B, Liderau R et al. A mesofluidic multiplex immunosensor for detection of circulating cytokeratin-positive cells in the blood of breast cancer patients. Biomed. Microdevices13(1), 1–9 (2010).
   Google Scholar
• Lin HK, Zheng S, Williams AJ et al. Portable filter-based microdevice for detection and characterization of circulating tumor cells. Clin. Cancer Res.16, 5011–5018 (2010).
   PubMed Web of Science ®Google Scholar
• Chung YK, Reboud J, Lee KC et al. An electrical biosensor for the detection of circulating tumor cells. Biosens. Bioelectron.26(5), 2520–2526 (2010).
   PubMedGoogle Scholar
• Moon HS, Kwon K, Kim SI et al. Continuous separation of breast cancer cells from blood samples using multi-orifice flow fractionation (MOFF) and dielectrophoresis (DEP). Lab. Chip11(6), 1118–1125 (2011).
   PubMed Web of Science ®Google Scholar
• Dharmasiri U, Njoroge SK, Witek MA et al. High-throughput selection, enumeration, electrokinetic manipulation, and molecular profiling of low-abundance circulating tumor cells using a microfluidic system. Anal. Chem.83(6), 2301–2309 (2011).
   PubMed Web of Science ®Google Scholar
• Galanzha EI, Shashkov EV, Kelly T, Kim JW, Yang L, Zharov VP. In vivo magnetic enrichment and multiplex photoacoustic detection of circulating tumor cells. Nat. Nanotechnol.4, 855–860 (2009).
   PubMed Web of Science ®Google Scholar
• Zemp RJ. Nanomedicine: detecting rare cancer cells. Nat. Nanotechnol.4, 798–799 (2009).
   PubMedGoogle Scholar
• Stathopoulou A, Vlachonikolis I, Mavroudis D et al. Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance. J. Clin. Oncol.20, 3404–3412 (2002).
   PubMed Web of Science ®Google Scholar
• Xenidis N, Perraki M, Kafousi M et al. Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real time polymerase chain reaction in node-negative breast cancer patients. J. Clin. Oncol.24, 3756–3762 (2006).
   PubMed Web of Science ®Google Scholar
• Chen Y, Zou TN, Wu ZP et al. Detection of cytokeratin 19, human mammaglobin and carcinoembryonic antigen-positive circulating tumor cells by three-marker reverse transcription-PCR assay and its relation to clinical outcome in early breast cancer. Int. J. Biol. Markers25, 59–68 (2010).
   PubMedGoogle Scholar
• Hayes DF, Smerage JR. Is there a role for circulating tumor cells in the management of breast cancer? Clin. Cancer Res.14, 57–70 (2008).
   Google Scholar
• Krishnamurthy S, Cristofanilli M, Singh B et al. Detection of minimal residual disease in blood and bone marrow in early stage breast cancer. Cancer116, 3330–3333 (2010).
   PubMed Web of Science ®Google Scholar
• Zhao S, Liu Y, Zhang Q et al. The prognostic role of circulating tumor cells (CTC) detected by RT-PCR in breast cancer: a meta-analysis of published literature. Breast Cancer Res. Treat. DOI: 10.1007/s10549-011-1379-4 (2011) (Epub ahead of print).
   Google Scholar
• Allen-Mersh TG, McCullough TK, Patel H et al. Role of circulating tumour cells in predicting recurrence after excision of primary colorectal carcinoma. Br. J. Surg.94, 96–105 (2007).
   PubMedGoogle Scholar
• Rahbari NN, Aigner M, Thorlund K et al. Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer. Gastroenterology138, 1714–1726 (2010).
   PubMed Web of Science ®Google Scholar
• Allen JE, El-Deiry W. Circulating tumor cells and colorectal cancer. Curr. Colorectal Cancer Rep.6, 212–220 (2010).
   PubMedGoogle Scholar
• Garrigos N, Gallego J, Guillen-Ponce C et al. Circulating tumor cell analysis as an early marker for relapse in stage II and III colorectal cancer patients: a pilot study. Clin. Transl. Oncol.12, 142–147 (2010).
   PubMedGoogle Scholar
• Thorsteinsson M, Jess P. The clinical significance of circulating tumor cells in non metastatic colorectal cancer – a review. Eur. J. Cancer Surg. DOI:10.1016/j.ejso.2011.01.025 (2011) (Epub ahead of print).
   Google Scholar
• Helo P, Cronin AM, Danila DC et al. Circulating prostate tumor cells detected by reverse transcription-PCR in men with localized or castration-refractory prostate cancer: concordance with CellSearch assay and association with bone metastases and with survival. Clin. Chem.55, 765–773 (2009).
   PubMed Web of Science ®Google Scholar
• Graves H, Czerniecki BJ. Circulating tumor cells in breast cancer patients: an evolving role in patient prognosis and disease progression. Patholog. Res. Int.2011, 621090 (2011).
   PubMedGoogle Scholar
• Harris L, Fritsche H, Mennel R et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J. Clin. Oncol.25, 5287–5312 (2007).
   PubMed Web of Science ®Google Scholar
• Armakolas A, Panteleakou Z, Nazos A et al. Detection of the circulating tumor cells in cancer patients. Future Oncol.6, 1849–1856 (2010).
   PubMedGoogle Scholar
• Cristofanilli M, Hayes DF, Budd GT et al. Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J. Clin. Oncol.23, 1420–1430 (2005).
   PubMed Web of Science ®Google Scholar
• De Bono JS, Scher HI, Montgomery RB et al. Circulating tumor cells predict survival benefit for treatment in metastatic castration resistant prostate cancer. Clin. Cancer Res.14, 6302–6309 (2008).
   PubMed Web of Science ®Google Scholar
• Cohen SJ, Punt CJ, Iannotti N et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J. Clin. Oncol.26, 3213–3221 (2008).
   PubMed Web of Science ®Google Scholar
• Hayes DF, Cristofanilli M, Budd GT et al. Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival. Clin. Cancer Res.12, 4218–4224 (2006).
   PubMed Web of Science ®Google Scholar
• Budd GT, Cristofanilli M, Ellis MJ et al. Circulating tumor cells versus imaging in predicting overall survival in metastatic breast cancer. Clin. Cancer Res.12, 6403–6409 (2006).
   PubMed Web of Science ®Google Scholar
• Fehm T, Becker S, Duerr-Stoerzer S et al. Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status. Breast Cancer Res.9, R74 (2007).
   PubMed Web of Science ®Google Scholar
• Ignatiadis M, Rothè F, Chaboteaux C et al. HER2-positive circulating tumor cells in breast cancer. PLoS One6, 1–6 (2011).
   Google Scholar
• Dawood S, Broglio K, Valero V et al. Circulating tumor cells in metastatic breast cancer: from prognostic stratification to modification of the staging system? Cancer113, 2422–2430 (2008).
   PubMed Web of Science ®Google Scholar
• Scher HI, Jia X, de Bono JS et al. Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data. Lancet Oncol.10, 233–239 (2009).
   PubMed Web of Science ®Google Scholar
• Cohen SJ, Punt CJ, Iannotti N et al. Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. Ann. Oncol.20, 1223–1229 (2009).
   PubMed Web of Science ®Google Scholar
• Attard G, de Bono JS. Utilizing circulating tumor cells: challenges and pitfalls. Curr. Opin. Genet. Dev.21, 50–58 (2011).
   PubMedGoogle Scholar